By Pushkala Aripaka and Maggie Fick (Reuters) -AstraZeneca shares rose on Thursday after the drugmaker said it could face a ...
The pharmaceutical giant's revenue jumped 21 per cent last year despite growing troubles over its presence in China, where it ...
In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...
Strong performances by AstraZeneca and mining stocks today helped the FTSE 100 index set a new record above 8700.The rise of ...
Most sectors at the FTSE 100 were up, boosted by strong corporate earnings. AstraZeneca, the FTSE 100’s most valuable company, rose 4.8 per cent following better than expected results. Shares in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results